Tag Archives | Namibia

Lucky Specials Brings Focus to TB Awareness Week in Namibia

Theresia Cloete was diagnosed with tuberculosis (TB) in 2002. She was put on treatment but after four months stopped taking her TB medication. Last year, she was diagnosed with drug-resistant TB. Like Cloete, many TB patients stop taking their life-saving medication before they are cured. She is now one of eight in-patients waiting for stabilization […]

Read full story · Comments { 0 }

Quality and Safety of HIV/AIDS Medicines in Namibia October 2015-September 2016

In the last five years, SIAPS has provided technical assistance to the Namibia Medicines Regulatory Council (NMRC) to strengthen its capacity for registration and quality testing by training technical staff in medicines dossier evaluation, developing guidelines for conducting the routine PMS of quality of medicines, and collecting medicine samples at selected ART and TB treatment sites for laboratory testing. SIAPS mentored and provided guidance and technical support to NMRC staff and other personnel in conducting efficient dossier reviews for the registration of ARVs, anti-TB, and other essential medicines. Consequently, intensive dossier review sessions were organized and fully funded by NMRC after effective and successful transition of the activity to NMRC for sustainability. SIAPS provided technical assistance to the NMRC to develop guidelines and collect medicine samples from seven priority regions (Kavango East and West, Khomas, Ohangwena, Omusati, Oshana, Oshikoto, and Zambezi) and one urban hotspot (Grootfontein [Otjozondjupa]).

Read full story · Comments are closed

Registration and Quality Assurance of ARVs and other Essential Medicines in Namibia

SIAPS provided technical assistance to facilitate the expedited assessment and registration of new and existing ARV formulations to support the implementation of the revised Namibian ART guidelines (dated January 2014). The technical assistance focused on improving the efficiency of the regulatory system so that the recommended new first-line fixed-dose combination ARVs that contain tenofovir and emtricitabine for adults; optimized ARV formulations for pediatric use; and other medicines for HIV and AIDS; TB; maternal, newborn, and child health (MNCH); and other public health diseases are assessed and considered for registration and made available for public procurement in a timely manner to benefit patients undergoing ART.

Read full story · Comments are closed

Strengthening Registration and Quality Assurance Systems for Generic ARVs, Related Medicines, and Devices in Namibia

In Namibia, USAID has been providing funding for technical assistance in the areas of pharmaceutical management and systems strengthening since 2003. During this period, the Rational Pharmaceutical Management Plus (RPM Plus) and Strengthening Pharmaceutical Systems (SPS) programs were implemented. RPM Plus supported interventions that largely focused on strengthening systems for the antiretroviral therapy (ART) and prevention of mother-to-child transmission of HIV programs. SPS focused on strengthening systems based on World Health Organization (WHO) building blocks, increasing the number of pharmaceutical personnel available for service delivery, strengthening policy coordination, and improving the regulatory functions of the NMRC. SIAPS focuses on further strengthening of regulatory and management systems in the pharmaceutical sector under the governance and health systems strategic area to support HIV and AIDS and other public health services.

Read full story · Comments are closed

SIAPS/Namibia Presents New Community-Based Antiretroviral Dispensing Services to the USAID Director for Southern Africa

The SIAPS team in Namibia joined other PEPFAR-implementing partners for the orientation of USAID’s newly appointed Director for Southern Africa, Mr. John Groarke. On September 27-28, 2017, Mr. Groake visited health facilities in the Omusati and Oshana regions in the North Central part of Namibia where he received updates on the progress of the community-based […]

Read full story · Comments { 0 }

SIAPS Namibia provides technical assistance to revise the National Medicines Policy

SIAPS Namibia staff helped the Pharmaceutical Services Division of the Ministry of Health and Social Services (MOHSS) of Namibia to revise the National Medicines Policy (NMP). The NMP, launched in 1998 and revised in 2012, provides guidelines and development objectives for the country’s pharmaceutical sectors.[1] It provides the framework within which pharmaceutical sector priorities are […]

Read full story · Comments { 0 }

Namibia’s Pharmaceutical Information Dashboard: A Key Resource for the UNAIDS Situation Room

The UNAIDS Situation Room is an innovative web-based platform that enables managers at all levels of the health system in Namibia to have access to HIV-related data in an easy and interactive manner. This tool uses automated, frequently updated data and data visualisation tools that are mobile and accessible at any time to help managers […]

Read full story · Comments { 0 }

Human Resource Capacity Development for ART and Pharmaceutical Services in Namibia, October 2014-September 2015

SIAPS Namibia applied the capacity building approach to support the Ministry of Health and Social Services to enhance the capacity of two local training institutions—UNAM-SoP and the NHTC—to train pharmacists and PAs, respectively. With SIAPS technical assistance for defining a career path for PAs, UNAM-SoP started training pharmacy technicians, a new cadre in Namibia. SIAPS also continued its efforts to enhance the capacity of individuals through pre- and in-service training to ensure that health workers have adequate skills to administer quality pharmaceutical services. The capacity building interventions were done through training workshops and on-the-job technical assistance provided during support supervisory visits (SSVs) and remotely.

Read full story · Comments are closed

Ensuring patient safety during HIV and TB treatment in Namibia

The SIAPS Namibia Project Director, Dr. Evans Sagwa, has advocated for adoption of strategies to ensure drug safety in TB and HIV treatment programs in the country. He made this call while delivering a public lecture on Friday, September 22, 2017, entitled “Strategies for optimizing patient safety in HIV and TB treatment programs in Namibia,” […]

Read full story · Comments { 0 }

Pediatric Antiretroviral Treatment Uptake, Treatment Adherence, Regimen Switches, and Retention in Care in Namibia

In Namibia, a preliminary review of EDT records suggests that children form a small proportion of the patients accessing ART in any given setting, nationally composing 8% of the patients on ART in the MoHSS facilities. Over the years, managing children has been complicated with formulations that have not been friendly for children, complicated regimens, and occasional stock-outs of pediatric ARVs. These challenges may increase the number of children that might receive suboptimal care, including delayed or no interventions in face of poor adherence, ultimately leading to suboptimal response to treatment. This can then increase the risk of HIV drug resistance and leads to short survival of HIV-infected children. Findings from this assessment will provide much needed evidence on trends in pediatric HIV treatment uptake, levels of adherence, and retention among those on treatment. Ultimately, the evidence generated will support MoHSS policy makers and leaders in modifying and strengthening interventions aimed at enhancing treatment uptake, adherence, retention, and viral load suppression among HIV-infected children in Namibia.

Read full story · Comments are closed